Radcliffe Capital Management’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Radcliffe Capital Management’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-514,999	Closed	-$30.3K	–	375
2023 Q3	$30.3K	Hold	514,999	–	–	﹤0.01%	231
2023 Q2	$11.8K	Hold	514,999	–	–	﹤0.01%	394
2023 Q1	$51.5K	Hold	514,999	–	–	﹤0.01%	329
2022 Q4	$5.26M	Hold	514,999	–	–	0.17%	190
2022 Q3	$5.14M	Hold	514,999	–	–	0.12%	260
2022 Q2	$5.08M	Hold	514,999	–	–	0.12%	261
2022 Q1	$5.07M	Hold	514,999	–	–	0.12%	224
2021 Q4	$5.05M	Buy	+514,999	New	+$243K	0.13%	158

Other funds holding PEPLW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Radcliffe Capital Management's PEPLW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q4 2023, closing a stake of 514,999 shares — an estimated $30.3K sold.

Radcliffe Capital Management first reported a position in PEPLW in Q4 2021 and held it in 8 quarters. The position peaked at $5.26M in Q4 2022. 17 funds tracked by Wall St. Rank hold PEPLW as of Q4 2023.

Radcliffe Capital Management reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q4 2023 after selling out during the quarter.
Radcliffe Capital Management sold 514,999 PepperLime Health Acquisition Corporation Warrrant shares in Q4 2023, an estimated $30.3K.
Radcliffe Capital Management first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 8 quarters.
Radcliffe Capital Management's PepperLime Health Acquisition Corporation Warrrant position peaked at $5.26M in Q4 2022.
17 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.